human
norovirus
primari
caus
agent
acut
gastroenter
press
public
health
burden
worldwid
current
vaccin
small
molecul
therapeut
avail
treatment
prophylaxi
noroviru
infect
noroviru
proteas
play
vital
role
viral
replic
gener
structur
nonstructur
protein
via
cleavag
viral
polyprotein
thu
molecul
inhibit
viral
proteas
may
potenti
therapeut
valu
describ
herein
structurebas
design
synthesi
vitro
cellbas
evalu
first
class
oxadiazolebas
permeabl
macrocycl
inhibitor
noroviru
proteas
human
norovirus
belong
genu
noroviru
famili
calicivirida
primari
caus
sporad
epidem
nonbacteri
gastroenter
outbreak
worldwid
noroviru
infect
associ
high
morbid
among
elderli
young
well
immunocompromis
patient
mortal
rate
among
children
develop
countri
estim
exceed
annual
six
noroviru
genogroup
givi
gi
gii
associ
human
infect
cluster
account
noroviru
outbreak
worldwid
devis
prophylact
andor
therapeut
intervent
noroviru
infect
present
challeng
due
high
transmiss
genet
divers
environment
stabil
prolong
viru
shed
display
norovirus
furthermor
human
norovirus
robustli
grow
cell
cultur
low
level
human
noroviru
report
grow
human
b
cell
lastli
current
optim
anim
model
diseas
consequ
mani
aspect
noroviru
biolog
pathogenesi
poorli
understood
noroviru
rna
genom
kb
positivesens
singl
strand
genom
compris
three
open
read
frame
encod
kda
polyprotein
proteolyt
cleav
gener
least
six
nonstructur
protein
rna
helicasentpas
vpg
proteas
rnadepend
rna
polymeras
rdrp
encod
noroviru
capsid
small
basic
protein
respect
process
polyprotein
effect
noroviru
cystein
proteas
chymotrypsinlik
fold
extend
bind
cleft
cyshisglu
catalyt
triad
prefer
substrat
recognit
sequenc
fyxlqgacorrespond
p
p
p
p
p
p
gln
residu
determin
primari
substrat
specif
enzym
x
h
q
e
subsit
display
degre
plastic
therefor
accommod
p
gln
glu
process
polyprotein
essenti
viral
replic
inhibit
envisag
fruit
avenu
investig
discoveri
norovirusspecif
antivir
approach
success
use
discoveri
therapeut
viral
diseas
recent
describ
array
inhibitor
includ
demonstr
vivo
efficaci
dipeptidyl
inhibitor
use
murin
noroviru
model
report
herein
result
structur
biochem
antivir
studi
novel
seri
oxadiazolebas
cell
permeabl
macrocycl
inhibitor
figur
noroviru
sever
disadvantag
associ
peptidederiv
drug
includ
high
conform
flexibl
suscept
proteolyt
degrad
poor
membran
permeabl
low
oral
bioavail
shortcom
frequent
mitig
depeptit
effect
way
depeptit
linear
peptid
macrocycl
preorgan
structur
rigid
character
macrocycl
inhibitor
frequent
enhanc
pharmacolog
activ
reduc
entrop
penalti
associ
bind
furthermor
increas
proteolyt
stabil
effect
macrocycl
cellular
permeabl
oral
bioavail
less
predict
howev
paramet
expect
augment
macrocycl
engag
intramolecular
hydrogen
bond
basi
consider
hypothes
tether
p
gln
residu
prefer
primari
substrat
specif
residu
noroviru
p
residu
side
chain
appropri
linear
peptid
use
linker
would
yield
macrocycl
scaffold
figur
potenti
capabl
particip
intramolecular
hydrogen
bond
via
ring
oxygen
nitrogen
atom
depend
orient
assum
heterocycl
ring
addit
design
consider
includ
ensur
ring
size
macrocycl
would
optim
term
allow
macrocycl
assum
conform
structur
motif
recogn
proteas
paramount
import
sinc
conform
would
allow
proper
dockingposit
inhibitor
activ
site
turn
would
orient
correctli
side
chain
p
p
residu
therebi
maxim
hydrogen
bond
hydrophob
bind
interact
lastli
length
linker
posit
heterocycl
ring
also
anticip
influenc
permeabl
potenc
impact
conform
macrocycl
vide
infra
converg
approach
use
synthesi
inhibitor
tabl
thu
fragment
first
assembl
illustr
scheme
fragment
synthes
coupl
appropri
zprotect
carboxyl
acid
tertbutyl
carbaz
use
edci
yield
bocprotect
hydrazid
boc
protect
group
remov
via
treatment
dri
hcldioxan
result
hydrazin
coupl
l
bocglutam
acid
ester
use
edcihobtdieadmf
yield
hydrazid
reaction
ptoluenesulfonyl
chloridediea
dri
ch
cn
yield
bocgroup
yield
coupl
l
bocleu
use
edci
hobtdieadmf
form
fragment
coupl
fragment
gener
leucinesubstitut
intermedi
scheme
correspond
cyclohexylalaninesubstitut
compound
prepar
coupl
compound
l
cyclohexylalanin
methyl
ester
give
ester
hydrolyz
correspond
carboxyl
acid
scheme
coupl
acid
l
glu
obzl
methyl
ester
yield
compound
treatment
compound
h
pdc
furnish
acycl
precursor
subsequ
macrolactam
yield
compound
upon
reduct
lithium
borohydrid
gener
correspond
alcohol
oxid
aldehyd
accomplish
use
dessmartin
periodinan
synthes
compound
list
tabl
inhibitori
activ
compound
toward
nv
well
antinoroviru
activ
nv
replicon
harbor
cell
establish
cell
determin
previous
describ
result
tabul
tabl
graphic
dosedepend
inhibit
nv
rna
replic
compound
shown
figur
screen
result
shown
tabl
indic
comparison
compound
versu
compound
clearli
evid
ring
size
profound
impact
inhibitori
activ
cellular
permeabl
seri
compound
b
except
compound
rest
inhibitor
rel
wellperm
cell
sever
inhibitor
display
singl
digit
inhibitori
concentr
ec
valu
cell
base
assay
nv
murin
c
contrast
acycl
dipeptidyl
transit
state
inhibitor
substitut
leu
residu
cha
residu
result
signific
improv
ic
ec
valu
presenc
cha
markedli
chang
potenc
compound
compound
suggest
fruit
strategi
optim
potenc
may
necessit
structur
modif
cap
addit
ec
valu
nv
cell
cultur
well
correl
tabl
suggest
potenc
permeabl
compound
consist
multipl
norovirus
order
establish
precis
mechan
action
inhibitor
illumin
conform
orient
linker
well
obtain
structur
inform
use
guid
optim
pharmacolog
activ
high
resolut
xray
crystal
structur
inhibitor
nv
determin
examin
activ
site
reveal
presenc
promin
electron
densiti
subunit
consist
inhibitor
coval
bound
cy
cyclohexyl
alanin
side
chain
nestl
hydrophob
subsit
figur
howev
inhibitor
major
macrocycl
disord
could
model
disord
consist
observ
approxim
xray
diffract
data
set
obtain
complex
surfac
represent
nv
color
residu
type
inhibitor
shown
figur
hydrogenbond
interact
nv
inhibitor
shown
figur
includ
multipl
hydrogen
bond
gln
inhibitor
backbon
serv
correctli
posit
inhibitor
activ
site
cleft
critic
hydrogen
bond
involv
gln
side
chain
residu
also
clearli
evid
inhibitor
howev
hydrogen
bond
observ
complex
inhibitor
due
disord
residu
bind
interact
well
flexibl
backbon
loop
postul
play
critic
role
enzym
recognit
lack
cellular
permeabl
inhibitor
support
absenc
intramolecular
hydrogen
bond
oxadiazol
ring
howev
permeabl
involv
interplay
mani
factor
besid
intramolecular
hydrogen
bond
notabl
interact
inhibitor
observ
sinc
loop
nv
span
consist
disord
thu
seem
macrocycl
ring
size
may
play
role
form
optim
hydrogen
bond
interact
nv
surprisingli
decreas
macrocycl
ring
atom
inhibitor
atom
inhibitor
result
disord
inhibitor
nearbi
residu
nv
order
gain
insight
understand
structur
determin
impact
potenc
cellular
permeabl
herculean
effort
expend
obtain
high
resolut
xray
crystal
structur
permeabl
inhibitor
albeit
without
success
although
crystal
obtain
nv
cocrystal
inhibitor
sampl
yield
weak
xray
diffract
properti
even
optim
crystal
condit
final
crystallograph
data
indic
oxadiazolebas
macrocycl
inhibitor
weaken
hbond
prospect
pharmacophor
element
effort
correl
crystal
structur
data
provid
tabl
structur
nv
superimpos
use
secondari
structur
match
gesamt
surpris
overal
structur
nv
similar
rmsd
atom
residu
order
conduct
direct
analysi
inhibitor
disord
portion
macrocycl
inhibitor
model
ideal
posit
compar
inhibitor
figur
notabl
shorter
ring
size
inhibitor
appear
move
inhibitor
slightli
away
loop
contain
preclud
format
hydrogen
bond
disord
residu
nearbi
loop
howev
inhibitor
abl
stabil
loop
region
format
hydrogen
bond
due
larger
ring
size
perhap
explain
observ
differ
ic
valu
tabl
inhibitor
abl
form
extra
hydrogen
bond
rel
inhibitor
shorten
macrocycl
ring
size
inhibitor
would
like
move
inhibitor
away
prevent
format
hydrogen
bond
loop
result
disord
residu
may
also
explain
crystal
obtain
inhibitor
produc
poor
diffract
dynam
conform
nearbi
loop
could
potenti
prevent
format
wellord
crystal
convers
shorter
macrocycl
ring
size
appear
conduc
permeabl
although
bind
nv
target
slightli
weaken
current
dire
need
develop
norovirusspecif
therapeut
prophylact
manag
noroviru
infect
studi
describ
herein
disclos
structurebas
design
first
seri
oxadiazolebas
permeabl
macrocycl
inhibitor
noroviru
proteas
insight
gain
studi
laid
solid
foundat
conduct
preclin
studi
focus
optim
potenc
pharmacokinet
reagent
dri
solvent
purchas
variou
chemic
supplier
aldrich
acro
organ
chemimpex
tci
america
oakwood
chemic
bachem
fisher
use
obtain
silica
gel
mesh
use
flash
chromatographi
purchas
sorbent
technolog
atlanta
ga
thin
layer
chromatographi
perform
use
analtech
silica
gel
plate
h
spectra
record
cdcl
dmsod
varian
nmr
spectromet
high
resolut
mass
spectrometri
hrm
experi
perform
univers
kansa
mass
spectrometri
lab
use
lct
premier
mass
spectromet
water
milford
equip
timeofflight
mass
analyz
electrospray
ion
sourc
visual
accomplish
use
uv
light
andor
iodin
revers
phase
hplc
util
determin
puriti
final
compound
puriti
stir
solut
nprotect
amino
acid
deriv
mmol
dri
ch
cl
ml
ad
edci
mmol
reaction
mixtur
stir
min
ambient
temperatur
tboc
hydrazid
mmol
ad
reaction
mixtur
stir
h
room
temperatur
solut
wash
aqueou
hcl
ml
satur
nahco
ml
brine
ml
organ
phase
dri
anhydr
na
filter
concentr
yield
desir
compound
yield
mp
solut
l
bocgluom
mmol
dri
dmf
ml
ad
edci
g
mmol
equiv
hobt
g
mmol
equiv
mixtur
stir
min
room
temperatur
separ
flask
solut
deprotect
compound
g
mmol
dri
dmf
ml
cool
treat
diisopropylethylamin
g
mmol
equiv
solut
stir
min
ad
solut
reaction
mixtur
stir
h
monitor
reaction
tlc
solvent
remov
vacuo
residu
partit
ethyl
acet
ml
aqueou
hcl
ml
layer
separ
organ
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
yield
desir
compound
yield
mp
yield
mp
yield
yield
mp
yield
mp
solut
compound
g
mmol
dri
acetonitril
ml
ad
ptoluenesulfonyl
chlorid
g
mmol
equiv
diea
g
mmol
reaction
mixtur
stir
h
room
temperatur
monitor
reaction
tlc
solvent
remov
vacuo
residu
partit
ethyl
acet
ml
aqueou
hcl
ml
ethyl
acet
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
crude
product
purifi
use
flash
chromatographi
yield
desir
oxadiazol
deriv
oil
yield
oil
yield
oil
yield
oil
yield
solut
ester
mmol
thf
ml
treat
lioh
aqueou
thf
ml
reaction
mixtur
stir
h
room
temperatur
disappear
ester
monitor
tlc
solvent
evapor
residu
dilut
water
ml
solut
acidifi
ph
use
hydrochlor
acid
ml
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
desir
compound
yield
mp
oil
yield
yield
mp
oil
yield
oil
yield
oil
yield
solut
l
bocglu
obzl
oh
g
mmol
dri
dmf
ml
ad
nahco
g
mmol
follow
methyl
iodid
g
mmol
reaction
mixtur
stir
h
room
temperatur
progress
reaction
monitor
tlc
solid
filter
solvent
remov
vacuo
residu
partit
ethyl
acet
ml
water
ml
ethyl
acet
layer
wash
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
yield
oili
product
purifi
flash
chromatographi
yield
compound
colorless
oil
oil
yield
solut
l
bocleuoh
mmol
dri
dmf
ml
ad
edci
g
mmol
equiv
hobt
g
mmol
equiv
reaction
mixtur
stir
min
room
temperatur
separ
flask
solut
deprotect
compound
g
mmol
dri
dmf
ml
cool
treat
diisopropylethylamin
diea
g
mmol
equiv
stir
min
ad
reaction
mixtur
solut
stir
h
monitor
reaction
tlc
solvent
remov
residu
partit
ethyl
acet
ml
aqueou
hcl
ml
ethyl
acet
layer
wash
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
yield
yellow
oil
purifi
flash
chromatographi
yield
oili
product
deblock
hcl
dioxan
yield
compound
solut
compound
g
mmol
dri
dmf
ml
ad
edci
g
mmol
equiv
mixtur
stir
min
room
temperatur
separ
flask
solut
deprotect
compound
g
mmol
dri
dmf
ml
cool
treat
diisopropylethylamin
diea
g
mmol
equiv
stir
min
ad
reaction
mixtur
solut
stir
h
monitor
reaction
tlc
solvent
remov
vacuo
residu
partit
ml
aqueou
hcl
ml
ethyl
acet
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
crude
product
purifi
flash
chromatographi
yield
desir
product
yield
mp
yield
yield
mp
yield
mp
solut
benzyl
ester
g
mmol
methanol
ml
mlg
ester
ad
palladium
carbon
g
mol
mixtur
shaken
parr
hydrogen
h
atm
h
monitor
reaction
tlc
reaction
mixtur
filter
celit
celit
bed
wash
methanol
filtrat
concentr
reduc
pressur
yield
compound
yield
mp
yield
mp
yield
mp
solut
compound
g
mmol
dri
dmf
ml
ad
edci
g
mmol
equiv
hobt
g
mmol
equiv
diea
g
mmol
equiv
mixtur
stir
h
room
temperatur
monitor
reaction
tlc
solvent
remov
residu
partit
ethyl
acet
ml
citric
acid
ml
ethyl
acet
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
crude
product
purifi
flash
chromatographi
yield
compound
yield
mp
yield
mp
yield
yield
mp
solut
ester
mmol
anhydr
thf
ml
ad
dropwis
lithium
borohydrid
thf
ml
mmol
follow
absolut
ethyl
alcohol
ml
reaction
mixtur
stir
room
temperatur
overnight
reaction
mixtur
acidifi
ad
potassium
bisulf
ph
solut
remov
solvent
left
residu
taken
ethyl
acet
ml
organ
layer
wash
brine
ml
dri
anhydr
sodium
sulfat
filter
concentr
yield
compound
hydroxymethyl
hydroxymethyl
solut
compound
g
mmol
dri
dmf
ml
ad
edci
g
mmol
equiv
hobt
g
mmol
equiv
mixtur
stir
min
room
temperatur
separ
flask
solut
l
cyclohexyl
alanin
methyl
ester
hydrochlorid
g
mmol
dri
dmf
ml
cool
treat
diisopropylethylamin
g
mmol
equiv
stir
min
ad
reaction
mixtur
solut
stir
h
monitor
reaction
tlc
solvent
remov
residu
partit
ethyl
acet
ml
aqueou
hcl
ml
ethyl
acet
layer
wash
satur
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
na
filter
concentr
crude
product
purifi
flash
chromatographi
yield
compound
oil
yield
oil
yield
oil
yield
oil
yield
solut
ester
mmol
thf
ml
treat
lioh
aqueou
ethanol
ml
reaction
mixtur
stir
h
room
temperatur
disappear
ester
monitor
tlc
solvent
evapor
residu
dilut
water
ml
solut
acidifi
ph
use
hydrochlorid
acid
ml
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
compound
yield
mp
oil
yield
oil
yield
yield
mp
yield
mp
studi
carri
describ
previous
nv
fluoresc
reson
energi
transfer
fret
assay
perform
use
fluorogen
substrat
edansdfhlqgpdabcyl
deriv
cleavag
site
nv
polyprotein
method
fret
assay
determin
ic
valu
proteas
inhibitor
describ
previous
lab
intens
integr
use
xd
laue
class
analysi
data
scale
perform
aimless
suggest
highest
probabl
laue
class
nv
mmm
nv
structur
solut
conduct
molecular
replac
phaser
use
previous
determin
isomorph
structur
inhibitor
bound
noroviru
pdb
code
search
model
structur
refin
manual
model
build
conduct
phenix
coot
respect
disord
side
chain
truncat
point
electron
densiti
could
observ
atom
refin
anisotrop
atom
displac
paramet
nv
structur
valid
conduct
molprob
figur
prepar
use
packag
coordin
structur
factor
deposit
wwpdb
access
code
nv
nv
refer
web
version
pubm
central
supplementari
materi
superposit
nv
complex
inhibitor
green
magenta
disord
portion
inhibitor
model
ideal
geometri
comparison
inhibitor
